nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—HTR1D—meninx—brain cancer	0.131	0.144	CbGeAlD
Xylometazoline—HTR1B—dura mater—brain cancer	0.125	0.136	CbGeAlD
Xylometazoline—HTR1D—dura mater—brain cancer	0.121	0.132	CbGeAlD
Xylometazoline—HTR1B—trigeminal nerve—brain cancer	0.0537	0.0587	CbGeAlD
Xylometazoline—HTR1D—trigeminal nerve—brain cancer	0.052	0.0568	CbGeAlD
Xylometazoline—HTR1B—cranial nerve—brain cancer	0.0383	0.0418	CbGeAlD
Xylometazoline—HTR1D—cranial nerve—brain cancer	0.037	0.0405	CbGeAlD
Xylometazoline—HTR1B—telencephalic ventricle—brain cancer	0.0311	0.034	CbGeAlD
Xylometazoline—HTR1D—telencephalic ventricle—brain cancer	0.0301	0.0329	CbGeAlD
Xylometazoline—HTR1B—ganglion—brain cancer	0.0194	0.0212	CbGeAlD
Xylometazoline—HTR1D—ganglion—brain cancer	0.0187	0.0205	CbGeAlD
Xylometazoline—HTR1B—blood vessel—brain cancer	0.0154	0.0168	CbGeAlD
Xylometazoline—HTR1D—blood vessel—brain cancer	0.0149	0.0163	CbGeAlD
Xylometazoline—ADRA1A—hindbrain—brain cancer	0.0109	0.0119	CbGeAlD
Xylometazoline—ADRA1D—telencephalon—brain cancer	0.00967	0.0106	CbGeAlD
Xylometazoline—HTR1B—brainstem—brain cancer	0.00842	0.00919	CbGeAlD
Xylometazoline—HTR1D—brainstem—brain cancer	0.00815	0.0089	CbGeAlD
Xylometazoline—HTR1B—telencephalon—brain cancer	0.00747	0.00816	CbGeAlD
Xylometazoline—HTR1D—telencephalon—brain cancer	0.00723	0.0079	CbGeAlD
Xylometazoline—ADRA1A—brainstem—brain cancer	0.00626	0.00684	CbGeAlD
Xylometazoline—ADRA1B—head—brain cancer	0.00616	0.00673	CbGeAlD
Xylometazoline—ADRA1D—endocrine gland—brain cancer	0.0061	0.00667	CbGeAlD
Xylometazoline—ADRA1D—head—brain cancer	0.00602	0.00658	CbGeAlD
Xylometazoline—ADRA1B—central nervous system—brain cancer	0.00562	0.00614	CbGeAlD
Xylometazoline—ADRA1A—telencephalon—brain cancer	0.00556	0.00607	CbGeAlD
Xylometazoline—ADRA1D—central nervous system—brain cancer	0.0055	0.00601	CbGeAlD
Xylometazoline—HTR1B—midbrain—brain cancer	0.00536	0.00586	CbGeAlD
Xylometazoline—ADRA2C—telencephalon—brain cancer	0.00529	0.00578	CbGeAlD
Xylometazoline—HTR1B—spinal cord—brain cancer	0.00523	0.00572	CbGeAlD
Xylometazoline—HTR1D—midbrain—brain cancer	0.00519	0.00567	CbGeAlD
Xylometazoline—HTR1B—endocrine gland—brain cancer	0.00471	0.00515	CbGeAlD
Xylometazoline—HTR1B—head—brain cancer	0.00465	0.00508	CbGeAlD
Xylometazoline—HTR1D—head—brain cancer	0.0045	0.00492	CbGeAlD
Xylometazoline—ADRA1B—brain—brain cancer	0.00446	0.00488	CbGeAlD
Xylometazoline—ADRA1D—brain—brain cancer	0.00437	0.00477	CbGeAlD
Xylometazoline—ADRA2C—pituitary gland—brain cancer	0.00431	0.00471	CbGeAlD
Xylometazoline—HTR1B—central nervous system—brain cancer	0.00425	0.00464	CbGeAlD
Xylometazoline—ADRA2A—telencephalon—brain cancer	0.00422	0.00462	CbGeAlD
Xylometazoline—ADRA2C—medulla oblongata—brain cancer	0.00416	0.00454	CbGeAlD
Xylometazoline—HTR1D—central nervous system—brain cancer	0.00411	0.00449	CbGeAlD
Xylometazoline—ADRA2C—midbrain—brain cancer	0.0038	0.00415	CbGeAlD
Xylometazoline—ADRA2C—spinal cord—brain cancer	0.00371	0.00405	CbGeAlD
Xylometazoline—ADRA2A—gonad—brain cancer	0.00353	0.00385	CbGeAlD
Xylometazoline—ADRA1A—endocrine gland—brain cancer	0.0035	0.00383	CbGeAlD
Xylometazoline—ADRA1A—head—brain cancer	0.00346	0.00378	CbGeAlD
Xylometazoline—ADRA2A—pituitary gland—brain cancer	0.00344	0.00376	CbGeAlD
Xylometazoline—HTR1B—brain—brain cancer	0.00337	0.00368	CbGeAlD
Xylometazoline—ADRA2A—medulla oblongata—brain cancer	0.00332	0.00363	CbGeAlD
Xylometazoline—ADRA2C—head—brain cancer	0.0033	0.0036	CbGeAlD
Xylometazoline—HTR1D—brain—brain cancer	0.00326	0.00356	CbGeAlD
Xylometazoline—ADRA1A—central nervous system—brain cancer	0.00316	0.00345	CbGeAlD
Xylometazoline—ADRA1A—cerebellum—brain cancer	0.00309	0.00337	CbGeAlD
Xylometazoline—ADRA2A—midbrain—brain cancer	0.00303	0.00331	CbGeAlD
Xylometazoline—ADRA2C—central nervous system—brain cancer	0.00301	0.00329	CbGeAlD
Xylometazoline—ADRA2A—spinal cord—brain cancer	0.00296	0.00323	CbGeAlD
Xylometazoline—ADRA2C—cerebellum—brain cancer	0.00294	0.00321	CbGeAlD
Xylometazoline—ADRA2A—endocrine gland—brain cancer	0.00266	0.00291	CbGeAlD
Xylometazoline—ADRA2A—head—brain cancer	0.00263	0.00287	CbGeAlD
Xylometazoline—ADRA1A—brain—brain cancer	0.00251	0.00274	CbGeAlD
Xylometazoline—ADRA2A—central nervous system—brain cancer	0.0024	0.00262	CbGeAlD
Xylometazoline—ADRA2C—brain—brain cancer	0.00239	0.00261	CbGeAlD
Xylometazoline—ADRA2A—cerebellum—brain cancer	0.00235	0.00256	CbGeAlD
Xylometazoline—ADRA2A—brain—brain cancer	0.00191	0.00208	CbGeAlD
Xylometazoline—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—brain cancer	7.9e-05	0.000933	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—GFAP—brain cancer	7.84e-05	0.000926	CbGpPWpGaD
Xylometazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	7.82e-05	0.000924	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—DLL1—brain cancer	7.8e-05	0.000921	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—GFAP—brain cancer	7.71e-05	0.000911	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ABR—brain cancer	7.66e-05	0.000905	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—IDH1—brain cancer	7.61e-05	0.000899	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—VAV1—brain cancer	7.58e-05	0.000895	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—GLI1—brain cancer	7.49e-05	0.000885	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—VAV1—brain cancer	7.46e-05	0.000881	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HEY1—brain cancer	7.43e-05	0.000878	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—ENO2—brain cancer	7.41e-05	0.000875	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GLI2—brain cancer	7.4e-05	0.000874	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SHH—brain cancer	7.35e-05	0.000868	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—PIK3CG—brain cancer	7.34e-05	0.000867	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HEY1—brain cancer	7.31e-05	0.000864	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—VAV1—brain cancer	7.29e-05	0.000861	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—DLL1—brain cancer	7.29e-05	0.000861	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—PIK3CG—brain cancer	7.19e-05	0.000849	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—DLL1—brain cancer	7.17e-05	0.000847	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SUFU—brain cancer	7.1e-05	0.000839	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TRPC6—brain cancer	7.08e-05	0.000837	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SMO—brain cancer	6.96e-05	0.000823	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PTCH1—brain cancer	6.96e-05	0.000823	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GLI1—brain cancer	6.96e-05	0.000822	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—GFAP—brain cancer	6.85e-05	0.000809	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—PIK3CG—brain cancer	6.81e-05	0.000804	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—VAV1—brain cancer	6.78e-05	0.0008	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—PIK3CG—brain cancer	6.67e-05	0.000787	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SHH—brain cancer	6.63e-05	0.000783	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—VAV1—brain cancer	6.62e-05	0.000782	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SUFU—brain cancer	6.6e-05	0.000779	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—PIK3CG—brain cancer	6.53e-05	0.000771	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—NOTCH2—brain cancer	6.5e-05	0.000768	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HEY1—brain cancer	6.49e-05	0.000767	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TRPC6—brain cancer	6.39e-05	0.000755	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—DLL1—brain cancer	6.37e-05	0.000752	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—NOTCH2—brain cancer	6.37e-05	0.000752	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GFAP—brain cancer	6.37e-05	0.000752	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—IL2—brain cancer	6.31e-05	0.000746	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SMO—brain cancer	6.29e-05	0.000743	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PTCH1—brain cancer	6.29e-05	0.000743	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—PIK3CG—brain cancer	6.28e-05	0.000742	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—VAV1—brain cancer	6.2e-05	0.000732	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SHH—brain cancer	6.19e-05	0.000732	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—VAV1—brain cancer	6.15e-05	0.000727	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SHH—brain cancer	6.1e-05	0.00072	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—VAV1—brain cancer	6.07e-05	0.000717	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HEY1—brain cancer	6.03e-05	0.000713	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—ENO2—brain cancer	6.02e-05	0.000711	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TRPC6—brain cancer	5.97e-05	0.000706	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—DLL1—brain cancer	5.92e-05	0.000699	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—IL2—brain cancer	5.9e-05	0.000697	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TRPC6—brain cancer	5.88e-05	0.000694	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PTCH1—brain cancer	5.87e-05	0.000694	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SMO—brain cancer	5.87e-05	0.000694	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SMO—brain cancer	5.78e-05	0.000683	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PTCH1—brain cancer	5.78e-05	0.000683	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—PIK3CG—brain cancer	5.7e-05	0.000674	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—PIK3CG—brain cancer	5.67e-05	0.00067	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—NOTCH2—brain cancer	5.57e-05	0.000658	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SHH—brain cancer	5.42e-05	0.00064	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—VEGFA—brain cancer	5.37e-05	0.000634	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—HES1—brain cancer	5.33e-05	0.00063	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—VAV1—brain cancer	5.31e-05	0.000627	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—PIK3CG—brain cancer	5.3e-05	0.000626	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TRPC6—brain cancer	5.22e-05	0.000617	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—HES1—brain cancer	5.22e-05	0.000617	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—PIK3CG—brain cancer	5.21e-05	0.000616	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—IL2—brain cancer	5.16e-05	0.00061	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—PIK3CG—brain cancer	5.15e-05	0.000608	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SMO—brain cancer	5.13e-05	0.000606	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PTCH1—brain cancer	5.13e-05	0.000606	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PDGFRA—brain cancer	5.08e-05	0.0006	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—IL2—brain cancer	5.06e-05	0.000597	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SHH—brain cancer	5.03e-05	0.000594	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—NOTCH2—brain cancer	5.03e-05	0.000594	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—VEGFA—brain cancer	5.01e-05	0.000592	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PDGFRA—brain cancer	4.97e-05	0.000587	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—SPP1—brain cancer	4.93e-05	0.000582	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TRPC6—brain cancer	4.85e-05	0.000573	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—SPP1—brain cancer	4.83e-05	0.00057	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—PIK3CG—brain cancer	4.81e-05	0.000568	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—VAV1—brain cancer	4.79e-05	0.000566	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—IL2—brain cancer	4.79e-05	0.000566	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SMO—brain cancer	4.77e-05	0.000563	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PTCH1—brain cancer	4.77e-05	0.000563	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—PIK3CG—brain cancer	4.73e-05	0.000559	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—NOTCH2—brain cancer	4.69e-05	0.000555	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—IL2—brain cancer	4.69e-05	0.000554	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—PIK3CG—brain cancer	4.63e-05	0.000547	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—NOTCH2—brain cancer	4.62e-05	0.000546	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—IL2—brain cancer	4.59e-05	0.000542	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—HES1—brain cancer	4.56e-05	0.000539	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—VAV1—brain cancer	4.48e-05	0.000529	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IRS2—brain cancer	4.46e-05	0.000527	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—IL2—brain cancer	4.42e-05	0.000522	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—VAV1—brain cancer	4.4e-05	0.00052	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IRS2—brain cancer	4.37e-05	0.000516	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PDGFRA—brain cancer	4.35e-05	0.000513	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—PIK3CG—brain cancer	4.3e-05	0.000508	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SPP1—brain cancer	4.22e-05	0.000498	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—PIK3CG—brain cancer	4.21e-05	0.000497	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—HES1—brain cancer	4.12e-05	0.000487	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—NOTCH2—brain cancer	4.1e-05	0.000485	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—VEGFA—brain cancer	4.07e-05	0.000481	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—TP53—brain cancer	4.06e-05	0.000479	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—IL2—brain cancer	4.01e-05	0.000474	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—IL2—brain cancer	3.99e-05	0.000471	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—PIK3CG—brain cancer	3.94e-05	0.000465	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—APC—brain cancer	3.94e-05	0.000465	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PDGFRA—brain cancer	3.92e-05	0.000463	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—VAV1—brain cancer	3.91e-05	0.000462	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—PIK3CG—brain cancer	3.91e-05	0.000462	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—APC—brain cancer	3.86e-05	0.000455	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—PIK3CG—brain cancer	3.86e-05	0.000455	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—HES1—brain cancer	3.85e-05	0.000455	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IRS2—brain cancer	3.82e-05	0.000451	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—NOTCH2—brain cancer	3.81e-05	0.00045	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SPP1—brain cancer	3.81e-05	0.00045	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—HES1—brain cancer	3.79e-05	0.000447	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—TP53—brain cancer	3.79e-05	0.000447	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—IL2—brain cancer	3.73e-05	0.00044	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—IL2—brain cancer	3.67e-05	0.000433	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PDGFRA—brain cancer	3.66e-05	0.000433	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—VAV1—brain cancer	3.64e-05	0.000429	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—IL2—brain cancer	3.62e-05	0.000428	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PDGFRA—brain cancer	3.61e-05	0.000426	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—EGFR—brain cancer	3.59e-05	0.000424	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SPP1—brain cancer	3.56e-05	0.00042	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—EGFR—brain cancer	3.51e-05	0.000415	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SPP1—brain cancer	3.5e-05	0.000414	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IRS2—brain cancer	3.44e-05	0.000407	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—PIK3CG—brain cancer	3.4e-05	0.000401	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—IL2—brain cancer	3.39e-05	0.0004	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—APC—brain cancer	3.37e-05	0.000398	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—PIK3CG—brain cancer	3.37e-05	0.000398	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—HES1—brain cancer	3.36e-05	0.000397	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—IL2—brain cancer	3.33e-05	0.000394	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—IL2—brain cancer	3.26e-05	0.000385	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IRS2—brain cancer	3.22e-05	0.00038	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PDGFRA—brain cancer	3.2e-05	0.000378	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IRS2—brain cancer	3.17e-05	0.000374	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—HES1—brain cancer	3.13e-05	0.000369	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SPP1—brain cancer	3.11e-05	0.000367	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—TP53—brain cancer	3.08e-05	0.000363	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—RELA—brain cancer	3.08e-05	0.000363	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—EGFR—brain cancer	3.07e-05	0.000363	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—ERBB2—brain cancer	3.06e-05	0.000361	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—PIK3CG—brain cancer	3.04e-05	0.000359	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—APC—brain cancer	3.04e-05	0.000359	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—IL2—brain cancer	3.03e-05	0.000358	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—RELA—brain cancer	3.01e-05	0.000356	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—ERBB2—brain cancer	2.99e-05	0.000354	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PDGFRA—brain cancer	2.98e-05	0.000352	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—IL2—brain cancer	2.96e-05	0.00035	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SPP1—brain cancer	2.89e-05	0.000341	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—APC—brain cancer	2.84e-05	0.000336	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—PIK3CG—brain cancer	2.84e-05	0.000336	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IRS2—brain cancer	2.81e-05	0.000332	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—APC—brain cancer	2.8e-05	0.00033	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—PIK3CG—brain cancer	2.8e-05	0.00033	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—EGFR—brain cancer	2.77e-05	0.000327	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—IL2—brain cancer	2.77e-05	0.000327	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—PIK3CG—brain cancer	2.76e-05	0.000326	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—IL2—brain cancer	2.75e-05	0.000325	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—IL2—brain cancer	2.71e-05	0.00032	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CCND1—brain cancer	2.7e-05	0.000319	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—CTNNB1—brain cancer	2.67e-05	0.000316	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CCND1—brain cancer	2.64e-05	0.000312	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—RELA—brain cancer	2.63e-05	0.000311	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—CTNNB1—brain cancer	2.62e-05	0.000309	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—ERBB2—brain cancer	2.62e-05	0.000309	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IRS2—brain cancer	2.61e-05	0.000309	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—EGFR—brain cancer	2.59e-05	0.000306	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—EGFR—brain cancer	2.55e-05	0.000301	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—PIK3CG—brain cancer	2.48e-05	0.000293	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—APC—brain cancer	2.48e-05	0.000293	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—RELA—brain cancer	2.38e-05	0.000281	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—IL2—brain cancer	2.37e-05	0.00028	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—ERBB2—brain cancer	2.36e-05	0.000279	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—VEGFA—brain cancer	2.35e-05	0.000278	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—STAT3—brain cancer	2.33e-05	0.000275	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CCND1—brain cancer	2.31e-05	0.000273	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—APC—brain cancer	2.31e-05	0.000273	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—PIK3CG—brain cancer	2.31e-05	0.000273	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—VEGFA—brain cancer	2.31e-05	0.000272	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—CTNNB1—brain cancer	2.29e-05	0.00027	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—STAT3—brain cancer	2.28e-05	0.00027	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—EGFR—brain cancer	2.26e-05	0.000267	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—RELA—brain cancer	2.22e-05	0.000262	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—ERBB2—brain cancer	2.21e-05	0.000261	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—RELA—brain cancer	2.19e-05	0.000258	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—ERBB2—brain cancer	2.17e-05	0.000257	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MYC—brain cancer	2.17e-05	0.000256	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—IL2—brain cancer	2.14e-05	0.000253	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MYC—brain cancer	2.12e-05	0.000251	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—EGFR—brain cancer	2.12e-05	0.00025	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—EGFR—brain cancer	2.1e-05	0.000248	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CCND1—brain cancer	2.09e-05	0.000247	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—EGFR—brain cancer	2.07e-05	0.000245	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—CTNNB1—brain cancer	2.07e-05	0.000244	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—VEGFA—brain cancer	2.02e-05	0.000238	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—IL2—brain cancer	2e-05	0.000236	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—STAT3—brain cancer	2e-05	0.000236	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—IL2—brain cancer	1.97e-05	0.000232	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CCND1—brain cancer	1.95e-05	0.00023	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—RELA—brain cancer	1.94e-05	0.000229	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—CTNNB1—brain cancer	1.93e-05	0.000228	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—ERBB2—brain cancer	1.93e-05	0.000228	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CCND1—brain cancer	1.92e-05	0.000227	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—CTNNB1—brain cancer	1.9e-05	0.000224	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MYC—brain cancer	1.85e-05	0.000219	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—VEGFA—brain cancer	1.82e-05	0.000215	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—EGFR—brain cancer	1.81e-05	0.000214	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—RELA—brain cancer	1.8e-05	0.000213	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—STAT3—brain cancer	1.8e-05	0.000213	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—ERBB2—brain cancer	1.79e-05	0.000212	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TP53—brain cancer	1.78e-05	0.00021	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—IL2—brain cancer	1.75e-05	0.000206	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TP53—brain cancer	1.74e-05	0.000206	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CCND1—brain cancer	1.7e-05	0.000201	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—VEGFA—brain cancer	1.7e-05	0.000201	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—CTNNB1—brain cancer	1.69e-05	0.000199	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—STAT3—brain cancer	1.68e-05	0.000199	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MYC—brain cancer	1.67e-05	0.000198	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—VEGFA—brain cancer	1.67e-05	0.000198	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—STAT3—brain cancer	1.66e-05	0.000196	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—EGFR—brain cancer	1.64e-05	0.000193	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—IL2—brain cancer	1.62e-05	0.000192	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CCND1—brain cancer	1.58e-05	0.000187	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—CTNNB1—brain cancer	1.57e-05	0.000185	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MYC—brain cancer	1.56e-05	0.000185	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MYC—brain cancer	1.54e-05	0.000182	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EGFR—brain cancer	1.53e-05	0.000181	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TP53—brain cancer	1.52e-05	0.00018	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EGFR—brain cancer	1.51e-05	0.000178	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—VEGFA—brain cancer	1.49e-05	0.000175	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—STAT3—brain cancer	1.47e-05	0.000174	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—VEGFA—brain cancer	1.38e-05	0.000163	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TP53—brain cancer	1.37e-05	0.000162	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MYC—brain cancer	1.37e-05	0.000161	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—STAT3—brain cancer	1.37e-05	0.000161	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EGFR—brain cancer	1.34e-05	0.000158	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TP53—brain cancer	1.28e-05	0.000152	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MYC—brain cancer	1.27e-05	0.00015	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TP53—brain cancer	1.26e-05	0.000149	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EGFR—brain cancer	1.24e-05	0.000147	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TP53—brain cancer	1.12e-05	0.000133	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TP53—brain cancer	1.04e-05	0.000123	CbGpPWpGaD
